tiprankstipranks
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT

Assertio Therapeutics (ASRT) Cash flow

988 Followers

Assertio Therapeutics Cash Flow

ASRT's free cash flow for Q4 2023 was $5.89M. For the 2023 fiscal year, ASRT's free cash flow was decreased by $-29.35M and operating cash flow was $5.71M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 49.60M$ 49.60M$ 78.60M$ 5.52M$ -65.57M$ 90.47M
Investing Cash Flow
$ 3.10M$ 3.10M$ -274.00K$ -18.52M$ 512.80M$ -1.48M
Financing Cash Flow
$ -44.20M$ -44.20M$ -7.79M$ 29.03M$ -468.55M$ -157.84M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 331.51M$ 73.44M$ 107.34M$ 36.81M$ 20.79M$ 42.11M
Income Tax Paid Supplemental Data
$ 4.03M$ 4.03M$ 6.91M--$ 4.40M
Interest Paid Supplemental Data
$ 3.65M$ 3.65M$ 7.75M$ 10.12M$ 17.60M$ 37.79M
Issuance Of Capital Stock
--$ 7.02M$ 44.86M$ 88.00K$ 251.00K
Issuance Of Debt
$ -10.50M$ -10.50M$ -4.83M---
Repayment Of Debt
$ -10.50M$ -10.50M$ -70.75M-$ -454.26M$ -153.25M
Free Cash Flow
$ 48.98M$ 48.98M$ 78.32M$ 5.47M$ -65.58M$ 88.99M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Assertio Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis